EKSO (Ekso Bionics Holdings, Inc. Common Stock) Stock Analysis - Politician Trades
Ekso Bionics Holdings, Inc. Common Stock (EKSO) is a publicly traded Healthcare sector company. As of May 21, 2026, EKSO trades at $11.80 with a market cap of $42.05M and a P/E ratio of -2.40. EKSO moved -3.56% today. Year to date, EKSO is +151.06%; over the trailing twelve months it is +62.87%. Its 52-week range spans $2.73 to $18.15. Rallies surfaces EKSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded EKSO stock?
Rallies tracks politician and congressional stock disclosures for EKSO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Jones Jason C bought 1.31K (~$15.50K) on Mar 16, 2026.
Wong Jerome bought 1.31K (~$15.50K) on Mar 16, 2026.
ASHER DANIEL bought 15.54K (~$191.16K) on Feb 19, 2026.
EKSO Analyst Consensus
EKSO analyst coverage data. Average price target: $0.00.
Common questions about EKSO
Which politicians traded EKSO stock?
Rallies tracks politician and congressional stock disclosures for EKSO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in EKSO?
Yes. Rallies tracks politician and congressional stock disclosures for EKSO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is EKSO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EKSO. It does not provide personalized investment advice.